Big news from Dana-Farber Cancer Institute regarding the FDA approval of revumenib for the treatment of relapsed acute leukemia! Gabrielle’s Angel Foundation funded Scott Armstrong, MD, PhD back in 2007 during the preliminary research of this project. These early efforts to understand how the cell makes use of menin, to explorations of the cell machinery […]

After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and immune systems from the ground up from a relatively small number of “seed” cells obtained from their donor. To achieve this, the donated cells must replicate again and again — and again.  It’s a cycle that might put […]

Exciting news out of Dana-Farber on a  the development of new menin-targeting agents that showed promise in clinical trials involving adults with acute myeloid leukemia (AML), one of the hardest-to-treat forms of leukemia. Scott Armstrong, MD, PhD, Gabrielle’s Angel Foundation Medical Research Award recipient in 2007 and current senior vice president for drug discovery and chief […]

With your support in 2023, we were able to fund 6 new individual researchers with grants of $225,000 each as well as co-funding with The Mark Foundation for Cancer Research 2 new collaborative research teams with grants of $500,000 each. Our grants are chosen by our outstanding Medical Advisory Board, assuring that the money that […]

Gabrielle’s Angel Foundation’s Medical Advisory Board recently selected 6 talented early career scientists to receive Medical Research Awards for a total of $1.35M in grants! Awards are $225,000 over a three year period. We are delighted to welcome these brilliant investigators to our Gabrielle’s Angels family! Stay tuned for spotlights on each grantee and their work throughout the rest of the […]

https://patch.com/new-jersey/newbrunswick/500k-grant-supports-exploration-therapies-rare-lymphomas

We are delighted to welcome Dr. Sarah Tasian to the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research! Sarah K Tasian, MD is a pediatric oncologist and physician-scientist at the Children’s Hospital of Philadelphia (CHOP) and an Associate Professor of Pediatrics at the University of Pennsylvania School of Medicine who is interested in […]

From the lab of Gabrielle’s Angels grantee Iannis Aifantis – their latest work on peptide:MHC class I expression & degradation and the discovery of a novel protein complex potentially important for T cell recognition in cancer. Immune-checkpoint blockade has revolutionized cancer treatment, but some cancers, such as acute myeloid leukemia (AML), do not respond or […]

We are thrilled to announce that we have selected the recipients of our first ever Mark Foundation – Gabrielle’s Angel Foundation Collaborative Grants. Co-funded with the Mark Foundation for Cancer Research, these two projects totaling $1M represent an amazing opportunity for us to re-invest in our grantees’ impactful work while helping to accelerate progress by bringing together scientists and institutions for collaboration. We are so grateful for […]

Congratulations to Zuzana Tothova, MD, PhD (Gabrielle’s Angels Grantee 2022) who is the recipient of the Doris Duke Foundation‘s Paragon Award for Research Excellence! This one-time recognition honors physician-scientists who have significantly advanced knowledge toward the prevention, diagnosis, and treatment of human disease or who have, through their professional contributions, improved the health outcomes of […]

A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier. This assay may improve detection of AML driven by KMT2A gene fusions and may affect treatment decision-making, assessing response […]

Daniel Herranz Benito, an associate professor in the Department of Pharmacology, recently received an $800,000 grant from the V Foundation for Cancer Research to further research T cell Acute Lymphoblastic Leukemia (T-ALL). Benito, who is also a resident researcher at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Barnabas Health, said this four-year grant will allow him […]